ORIGINAL PAPERS
IN PEER REVIEWED JOURNALS

Iannitto E, Bellei M, Amorim S, Ferreri AJM, Marcheselli L, Cesaretti M, Haioun C, Mancuso S, Bouabdallah K, Gressin R, Tripodo C, Traverse-Glehen A, Baseggio L, Zupo S, Stelitano C, Castagnari B, Patti C, Alvarez I, Liberati AM, Merli M, Gini G, Cabras MG, Dupuis J, Tessoulin B, Perrot A, Re F, Palombi F, Gulino A, Zucca E, Federico M, Thieblemont C.
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.
Br J Haematol. 2018 Nov 8.
Abstract
Ceriani L, Milan L, Martelli M, Ferreri AJM, Cascione L, Zinzani PL, Di Rocco A, Conconi A, Stathis A, Cavalli F, Bellei M, Cozens K, Porro E, Giovanella L, Johnson PW, Zucca E.
Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma.
Blood. Jul 12;132(2):179-186. doi: 10.1182/blood-2018-01-826958.
Abstract
Johnson PW, Thieblemont C, Zucca E.
Tailoring treatment for MALT lymphoma patients: where do we stand now?
Oncotarget. 2017 Dec 6;8(70):114422-114423.
Abstract
Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, La Rosée P, Binder M, Fabbri A, Torri V, Minacapelli E, Falautano M, Ilariucci F, Ambrosetti A, Roth A, Hemmaway C, Johnson P, Linton KM, Pukrop T, Sønderskov Gørløv J, Balzarotti M, Hess G, Keller U, Stilgenbauer S, Panse J, Tucci A, Orsucci L, Pisani F, Levis A, Krause SW, Schmoll HJ, Hertenstein B, Rummel M, Smith J, Pfreundschuh M, Cabras G, Angrilli F, Ponzoni M, Deckert M, Politi LS, Finke J, Reni M, Cavalli F, Zucca E, Illerhaus G; International Extranodal Lymphoma Study Group (IELSG).
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.
Lancet Haematol. 2017 Nov;4(11):e510-e523. doi: 10.1016/S2352-3026(17)30174-6.
Abstract
Thieblemont C, Cascione L, Conconi A, Kiesewetter B, Raderer M, Gaidano G, Martelli M, Laszlo D, Coiffier B, Lopez Guillermo A, Torri V, Cavalli F, Johnson PW, Zucca E.
A MALT lymphoma prognostic index generated from the dataset of the IELSG-19 prospective clinical trial.
Blood. 2017 Sep 21;130(12):1409-1417. doi: 10.1182/blood-2017-03-771915.
Abstract
Zucca E, Conconi A, Martinelli G, Bouabdallah R, Tucci A, Vitolo U, Martelli M, Pettengell R, Salles G, Sebban C, Guillermo AL, Pinotti G, Devizzi L, Morschhauser F, Tilly H, Torri V, Hohaus S, Ferreri AJM, Zachée P, Bosly A, Haioun C, Stelitano C, Bellei M, Ponzoni M, Moreau A, Jack A, Campo E, Mazzucchelli L, Cavalli F, Johnson P, Thieblemont C.
Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.
J Clin Oncol. 2017 Jun 10;35(17):1905-1912. doi: 10.1200/JCO.2016.70.6994.
Abstract
ielsg
Ceriani L, Martelli M, Conconi A, Zinzani PL, Ferreri AJM, Botto B, Stelitano C, Gotti M, Cabras MG, Rigacci L, Giovanella L, Zucca E, Johnson PWM.
Prognostic models for primary mediastinal (thymic) B-cell lymphoma derived from 18-FDG PET/CT quantitative parameters in the International Extranodal Lymphoma Study Group (IELSG) 26 study.
Br J Haemalot. 2017 May 9. doi: 10.1111/bjh.14728.
Abstract

ielsg
Ceriani L, Martelli M, Gospodarowicz MK, Ricardi U, Ferreri AJ, Chiappella A, Stelitano C, Balzarotti M, Cabrera ME, Cunningham D, Guarini A, Zinzani PL, Giovanella L, Johnson PW, Zucca E.
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma.
Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):42-49. doi: 10.1016/j.ijrobp.2016.09.031.
Abstract
ielsg
Sammassimo S, Pruneri G, Andreola G, Montoro J, Steffanoni S, Nowakowski GS, Gandini S, Negri M, Habermann TM, Raderer M, Li ZM, Zinzani PL, Adam P, Zucca E, Martinelli G.
A retrospective international study on primary extranodal marginal zone lymphoma of the lung (BALT lymphoma) on behalf of International Extranodal Lymphoma Study Group (IELSG).
Hematol Oncol. 2016 Dec;34(4):177-183. doi: 10.1002/hon.2243.
Abstract
ielsg
Ceriani L, Barrington S, Biggi A, Malkowski B, Metser U, Versari A, Martelli M, Davies A, Johnson PW, Zucca E, Chauvie S.
Training improves the interobserver agreement of the expert positron emission tomography review panel in primary mediastinal B-cell lymphoma: interim analysis in the ongoing International Extranodal Lymphoma Study Group-37 study.
Hematol Oncol. 2016 Aug 22. doi: 10.1002/hon.2339. [Epub ahead of print]
ielsg
Ferreri AJ, Cwynarski K, Pulczynski E, Ponzoni M, Deckert M, Politi LS, Torri V, Fox CP, Rosée PL, Schorb E, Ambrosetti A, Roth A, Hemmaway C, Ferrari A, Linton KM, Rudà R, Binder M, Pukrop T, Balzarotti M, Fabbri A, Johnson P, Gørløv JS, Hess G, Panse J, Pisani F, Tucci A, Stilgenbauer S, Hertenstein B, Keller U, Krause SW, Levis A, Schmoll HJ, Cavalli F, Finke J, Reni M, Zucca E, Illerhaus G; International Extranodal Lymphoma Study Group (IELSG).
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
Lancet Haematol. 2016 May;3(5):e217-27. doi: 10.1016/S2352-3026(16)00036-3.
Abstract
ielsg
Jackson AE, Mian M, Kalpadakis C, Pangalis GA, Stathis A, Porro E, Conconi A, Cortelazzo S, Gaidano G, Lopez Guillermo A, Johnson PW, Martelli M, Martinelli G, Thieblemont C, McPhail ED, Copie-Bergman C, Pileri SA, Jack A, Campo E, Mazzucchelli L, Ristow K, Habermann TM, Cavalli F, Nowakowski GS, Zucca E.
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41).
Oncologist. 2015 Oct;20(10):1149-53. doi: 10.1634/theoncologist.2015-0180.
Abstract
ielsg
Ceriani L, Martelli M, Zinzani PL, Ferreri AJM, Botto B, Stelitano C, Gotti M, Cabras MG, Rigacci L, Gargantini L, Merli G, Pinotti G, Mannina D, Luminari S, Stathis A, Russo E, Cavalli F, Giovanella L, Johnson PWM, Zucca E.
Utility of Baseline 18FDG PET/CT Functional Parameters in defining prognosis of Primary Mediastinal (Thymic) Large B-Cell Lymphoma.
Blood. 2015 Aug 20;126(8):950-6. doi: 10.1182/blood-2014-12-616474.
Abstract
ielsg
THE CLINICAL FEATURES, MANAGEMENT AND PROGNOSIS OF PRIMARY AND SECONDARY INDOLENT LYMPHOMA OF THE BONE: A RETROSPECTIVE STUDY OF THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (THE IELSG #14 STUDY)
Govi S, Christie D, Mappa S, Marturano E, Bruno Ventre M, Messina C, Gracia Medina EA, Porter D, Radford J, Heo DS, Park Y, Pro B, Jayamohan J, Pavlakis N, Zucca E, Gospodarowicz M, Ferreri AJ on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Leukemia & Lymphoma 2014 2014 Aug;55(8):1796-9.
Abstract
ielsg
CLINICAL ACTIVITY OF EVEROLIMUS IN RELAPSED/REFRACTORY MARGINAL ZONE B-CELL LYMPHOMAS: RESULTS OF A PHASE II STUDY OF THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP
Conconi A, Raderer M, Franceschetti S, Devizzi L, Ferreri AJ, Magagnoli M, Arcaini L, Zinzani PL, Martinelli G, Vitolo U, Kiesewetter B, Porro E, Stathis A, Gaidano G, Cavalli F, Zucca E
British Journal of Haematology 2014 Jul;166(1):69-76
Abstract
ielsg
[18F]FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY PREDICTS SURVIVAL AFTER CHEMOIMMUNOTHERAPY FOR PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA: RESULTS OF THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP IELSG-26 STUDY.
Martelli M, Ceriani L, Zucca E, Zinzani PL, Ferreri AJ, Vitolo U, Stelitano C, Brusamolino E, Cabras MG, Rigacci L, Balzarotti M, Salvi F, Montoto S, Lopez-Guillermo A, Finolezzi E, Pileri SA, Davies A, Cavalli F, Giovanella L, Johnson PW.
J Clin Oncol. 2014 Jun 10;32(17):1769-75.

Abstract
ielsg
CLINICAL FEATURES, MANAGEMENT AND PROGNOSIS OF AN INTERNATIONAL SERIES OF 161 PATIENTS WITH LIMITED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA OF THE BONE (THE IELSG-14 STUDY)
Bruno Ventre M, Ferreri AJ, Gospodarowicz M, Govi S, Messina C, Porter D, Radford J, Heo DS, Park Y, Martinelli G, Taylor E, Lucraft H, Hong A, Scarfò L, Zucca E, Christie D on behalf of the International Extranodal Lymphoma Study Group (IELSG)
The Oncologist 2014 Mar;19(3):291-8.
Abstract
ielsg
CLINICAL FEATURES, MANAGEMENT AND PROGNOSIS OF MULTIFOCAL PRIMARY BONE LYMPHOMA: A RETROSPECTIVE STUDY OF THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (THE IELSG 14 STUDY)
Messina C, Ferreri AJ, Govi S, Bruno-Ventre M, Gracia Medina EA, Porter D, Radford J, Heo DS, Park HY, Pro B, Jayamohan J, Visco C, Scarfò L, Zucca E, Gospodarowicz M, Christie D; the International Extranodal Lymphoma Study Group (IELSG)
British Journal of Haematology 2014 Mar; 164(6): 834-840
Abstract
ielsg
THE CLINICAL FEATURES, MANAGEMENT AND PROGNOSTIC EFFECTS OF PATHOLOGICAL FRACTURES IN A MULTICENTER SERIES OF 373 PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA OF THE BONE
Govi S, Christie D, Messina C, Bruno Ventre M, Gracia Medina EA, Porter D, Radford J, Heo DS, Park Y, Martinelli G, Taylor E, Lucraft H, Ballova V, Zucca E, Gospodarowicz M, Ferreri AJ on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Annals of Oncology
2014 Jan; 25(1): 176-181
Abstract
ielsg
EARLY-STAGE DIFFUSE LARGE B CELL LYMPHOMA OF THE HEAD AND NECK: CLINICO-BIOLOGICAL CHARACTERIZATION AND 18 YEAR FOLLOW-UP OF 488 PATIENTS (IELSG 23 STUDY)
Mian M, Capello D, Ventre MB, Grazio D, Svaldi M, Rossi A, Tsang R, Gospodarowicz MK, Oldani E, Federico M, Luminari S, Marcheselli L, Pogliani EM, Rossini F, Cabrera ME, Martelli M, Gutierrez-Garcia G, Busetto M, Visco C, Fiegl M, Rossi D, Gaidano G, Cavalli F, Zucca E, Rambaldi A, Cortelazzo S; on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Annals of Hematology
2014 Jan; 93: 221-231
Abstract
ielsg
ADDITION OF RITUXIMAB TO CHLORAMBUCIL PRODUCES SUPERIOR EVENT-FREE SURVIVAL IN THE TREATMENT OF PATIENTS WITH EXTRANODAL MARGINAL-ZONE B-CELL LYMPHOMA: 5-YEAR ANALYSIS OF THE IELSG-19 RANDOMIZED STUDY
E Zucca, A Conconi, D Laszlo, A López-Guillermo, R Bouabdallah, B Coiffier, C Sebban, F Jardin, U Vitolo, F Morschhauser, SA Pileri, C Copie-Bergman, E Campo, A Jack, I Floriani, P Johnson, M Martelli, F Cavalli, G Martinelli and C Thieblemont
Journal of Clinical Oncology
2013 Feb 10; 31(5): 565-72
Abstract
ielsg
LONG-TERM OUTCOME FOR GASTRIC MARGINAL ZONE LYMPHOMA TREATED WITH RADIOTHERAPY: A RETROSPECTIVE, MULTI-CENTRE, INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP STUDY
A. Wirth, M. Gospodarowicz, B.M.P. Aleman, M. Bressel, A. Ng, M. Chao, R.T. Hoppe, C. Thieblemont, R. Tsang, L. Moser, L. Specht, T. Szpytma, A. Lennard, J.F. Seymour and E. Zucca
Annals of Oncology 2013 May; 24(5): 1344-51
Abstract
ielsg
ROLE OF RADIOTHERAPY IN PATIENTS WITH EARLY-STAGE DIFFUSE LARGE B-CELL LYMPHOMA OF WALDEYER'S RING IN REMISSION AFTER ANTHRACYCLINE-CONTAINING CHEMOTHERAPY
M Mian, AJM Ferreri, A Rossi, A Conconi, R Tsang, MK Gospodarowicz, E Oldani, M Federico, S Luminari, EM Pogliani, F Rossini, ME Cabrera, M Martelli, G Gutierrez-Garcia, M Busetto, F Cavalli, E Zucca, A Rambaldi and S Cortelazzo; for the International Extranodal Lymphoma Study Group (IELSG)
Leukemia and Lymphoma 2013 Jan; 54(1): 62–68
Abstract
ielsg
GELA HISTOLOGICAL SCORING SYSTEM FOR POST-TREATMENT BIOPSIES OF PATIENTS WITH GASTRIC MALT LYMPHOMA IS FEASIBLE AND RELIABLE IN ROUTINE PRACTICE
Copie-Bergman C, Wotherspoon AC, Capella C, Motta T, Pedrinis E, Pileri SA, Bertoni F, Conconi A, Zucca E, Ponzoni M, Ferreri AJ
British Journal of Haematology 2013 Jan; 160(1): 47-52
Abstract
ielsg
CHLAMYDOPHILA PSITTACI ERADICATION WITH DOXYCYCLINE AS FIRST-LINE TARGETED THERAPY FOR OCULAR ADNEXAE LYMPHOMA: FINAL RESULTS OF AN INTERNATIONAL PHASE II TRIAL
A.J.M. Ferreri, S. Govi, E. Pasini, S. Mappa, F. Bertoni, F. Zaja, C. Montalban, C. Stelitano, M.E. Cabrera, A. Giordano Resti, L. Salvatore Politi, C. Doglioni, F. Cavalli, E. Zucca, M. Ponzoni and R. Dolcetti
Jurnal of Clinical Oncology 2012 Aug 20; 30(24): 2988-94
Abstract
ielsg
PRIMARY BONE MARROW LYMPHOMA: AN UNCOMMON EXTRANODAL PRESENTATION OF AGGRESSIVE NON-HODGKIN LYMPHOMAS
Martinez A, Ponzoni M, Agostinelli C, Hebeda KM, Matutes E, Peccatori J, Campidelli C, Espinet B, Perea G, Acevedo A, Mehrjardi AZ, Martinez-Bernal M, Gelemur M, Zucca E, Pileri S, Campo E, Lopez-Guillermo A and Rozman M on behalf of the International Extranodal Lymphoma Study Group
The American Journal of Surgical Pathology 2012 Feb; 36(2): 296–304
Abstract
ielsg
HEPATITIS C VIRUS AND GBV-C VIRUS PREVALENCE AMONG PATIENTS WITH B-CELL LYMPHOMA IN DIFFERENT EUROPEAN REGIONS: A CASE-CONTROL STUDY OF THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP
Nicolosi Guidicelli S, Lopez-Guillermo A, Falcone U, Conconi A, Christinat A, Rodriguez-Abreu D, Grisanti S, Lobetti-Bodoni C, Piffaretti JC, Johnson PW, Mombelli G, Cerny A, Montserrat E, Cavalli F and Zucca E
Hematological Oncology
2012 Sept; 30(3): 137-42
Abstract
ielsg
FIRST-LINE TREATMENT FOR PRIMARY TESTICULAR DIFFUSE LARGE B-CELL LYMPHOMA WITH RITUXIMAB-CHOP, CNS PROPHYLAXIS, AND CONTRALATERAL TESTIS IRRADIATION: FINAL RESULTS OF AN INTERNATIONAL PHASE II TRIAL
Vitolo U, Chiappella A, Ferreri AJ, Martelli M, Baldi I, Balzarotti M, Bottelli C, Conconi A, Gomez H, Lopez-Guillermo A, Martinelli G, Merli F, Novero D, Orsucci L, Pavone V, Ricardi U, Storti S, Gospodarowicz MK, Cavalli F, Sarris AH, Zucca E
Journal of Clinical Oncology
2011 July; 29(20): 2766-2772
Abstract
ielsg
HIGH RESPONSE RATE AND IMPROVEMENT OF LONG-TERM SURVIVAL WITH COMBINED TREATMENT MODALITIES IN PATIENTS WITH POOR-RISK PRIMARY THYROID DIFFUSE LARGE B-CELL LYMPHOMA: AN INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP AND INTERGRUPPO ITALIANO LINFOMI STUDY
Mian M, Gaidano G, Conconi A, Tsang R, Gospodarowicz MK, Rambaldi A, Rossi A, Oldani E, Federico M, Luminari S, Bellei M, Pogliani EM, Rossini F, Cabrera ME, Martelli M, Lopez-Guillermo A, Busetto M, Cavalli F, Zucca E and Cortelazzo S
Leukemia and Lymphoma 2011 May; 52(5): 823-832
Abstract
ielsg
CLIPI: A NEW PROGNOSTIC INDEX FOR INDOLENT CUTANEOUS B CELL LYMPHOMA PROPOSED BY THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG 11)
Mian M, Marcheselli L, Luminari S, Federico M, Cantonetti M, Sarris AH, Rossi A, Rambaldi A, Frontani M, Devizzi L, Gianni AM, Busetto M, Berti E, Martinelli G, Tsang RW, Ferreri AJ, Pinotti G, Pogliani E, Zucca E, Cortelazzo S
Annals of Hematology 2011 Apr; 90(4): 401-408
Abstract
ielsg
CLINICAL ACTIVITY OF BORTEZOMIB IN RELAPSED/REFRACTORY MALT LYMPHOMAS: RESULTS OF A PHASE II STUDY OF THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG)
Conconi A, Martinelli G, Lopez-Guillermo A, Zinzani PL, Ferreri AJ, Rigacci L, Devizzi L, Vitolo U, Luminari S, Cavalli F, Zucca E
Annals of Oncology 2011; 22(3): 689-695
Abstract
ielsg
METHOTREXATE AREA UNDER THE CURVE IS AN IMPORTANT OUTCOME PREDICTOR IN PATIENTS WITH PRIMARY CNS LYMPHOMA: A PHARMACOKINETIC-PHARMACODYNAMIC ANALYSIS FROM THE IELSG NO. 20 TRIAL
Joerger M, Huitema ADR, Krähenbühl S, Schellens JHM, Cerny T, Reni M, Zucca E, Cavalli F and Ferreri AJM
British Journal of Cancer 2010; 102:673-677
Abstract
ielsg
HIGH-DOSE CYTARABINE PLUS HIGH-DOSE METHOTREXATE VERSUS HIGH-DOSE METHOTREXATE ALONE IN PATIENTS WITH PRIMARY CNS LYMPHOMA: A RANDOMISED PHASE 2 TRIAL
AJM Ferreri, M Reni, M Foppoli, M Martelli, GA Pangalis, M Frezzato, MG Cabras, A Fabbri, G Corazzelli, F Ilariucci, G Rossi, R Soffietti, C Stelitano, D Vallisa, F Zaja, L Zoppegno, GM Aondio, G Avvisati, M Balzarotti, AA Brandes, J Fajardo, H Gomez, A Guarini, G Pinotti, L Rigacci, C Uhlmann, P Picozzi, P Vezzulli, M Ponzoni, E Zucca, F Caligaris-Cappio, F Cavalli, on behalf of the International Extranodal Lymphoma Study Group (IELSG)
The Lancet 2009 October; 374: 1512-20
Abstract
ielsg
EARLY STAGE GASTRIC DIFFUSE LARGE B-CELL LYMPHOMAS: RESULTS OF A RANDOMIZED TRIAL COMPARING CHEMOTHERAPY ALONE VERSUS CHEMOTHERAPY + INVOLVED FIELD RADIOTHERAPY
G. Martinelli, F. Gigli, L. Calabrese, PF. Ferrucci E. Zucca, C. Crosta, G. Pruneri, L. Preda, G. Piperno, M. Gospodarowicz, F. Cavalli, H. Moreno Gomez
Leukemia and Lymphoma 2009 Jun; 50(6): 925-31
Abstract
ielsg
PRIMARY FOLLICULAR AND MARGINAL-ZONE LYMPHOMA OF THE BREAST: CLINICAL FEATURES, PROGNOSTIC FACTORS AND OUTCOME. A STUDY BY THE INTERNATIONAL EXTRA-NODAL LYMPHOMA STUDY
G. Martinelli, G. Ryan, J.F. Seymour, L. Nassi, S. Steffanoni, A. Alietti, L. Calabrese, G. Pruneri, L. Santoro, M. Kuper-Hommel, R. Tsang, PL. Zinzani, A. Taghian E. Zucca, F. Cavalli
Annals of Oncology 2009 Dec; 20(12):1993-9

Abstract
ielsg
CHLORAMBUCIL VERSUS OBSERVATION AFTER ANTI-HELICOBACTER THERAPY IN GASTRIC MALT LYMPHOMAS: RESULTS OF THE INTERNATIONAL RANDOMISED LY03 TRIAL
Hancock BW, Qian W, Linch D, Delchier JC, Smith P, Jakupovic I, Burton C, Souhami R, Wotherspoon A, Copie-Bergman C, Capella C, Traulle C, Levy M, Cortelazzo S, Ferreri AJ, Ambrosetti A, Pinotti G, Martinelli G, Vitolo U, Cavalli F, Gisselbrecht C, Zucca E
British Journal of Haematology
2009 Feb; 144(3): 367-75
Abstract
ielsg
CAN RITUXIMAB CHANGE THE USUALLY DISMAL PROGNOSIS OF PATIENTS WITH INTRAVASCULAR LARGE B-CELL LYMPHOMA
Ferreri AJ, Dognini GP, Govi S, Crocchiolo R, Bouzani M, Bollinger CR, D'Incan M, Delaporte E, Hamadani M, Jardin F, Martusewicz-Boros M, Montanari M, Szomor A, Zucca E, Cavalli F, Ponzoni M.
Journal of Clinical Oncology 2008 October; correspondence
ielsg
THE ADDITION OF RITUXIMAB TO ANTHRACYCLINE-BASED CHEMOTHERAPY SIGNIFICANTLY IMPROVES OUTCOME IN 'WESTERN' PATIENTS WITH INTRAVASCULAR LARGE B-CELL LYMPHOMA
AJM. Ferreri, GP. Dognini, O. Bairey, A. Szomor, C. Montalbán, B. Horvath, J. Demeter, L. Uziel, R. Soffietti, JF. Seymour, A. Ambrosetti, R. Willemze, M. Martelli, G. Rossi, A. Candoni, A. De Renzo, C. Doglioni, E. Zucca, F. Cavalli, M. Ponzoni
British Journal of Haematology 2008 October; 143(2): 253-257
Abstract
iels
PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE BREAST: PROGNOSTIC FACTORS AND OUTCOMES OF A STUDY BY THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP
Ryan G, Martinelli G, Kuper-Hommel M, Tsang R, Pruneri G, Yuen K, Roos D, Lennard A, Devizzi L, Crabb S, Hossfeld D, Pratt G, Dell'olio M, Choo SP, Bociek RG, Radford J, Lade S, Gianni AM, Zucca E, Cavalli F, Seymour JF
Annals of Oncology 2008; 19(2): 233-241
Abstract
iels
CHROMOSOME INSTABILITY AND TRANSLOCATION t(11;18) IN PRIMARY GASTRIC MARGINAL ZONE B-CELL LYMPHOMA OF MALT-TYPE
M.G. Tibiletti1, K. Milani, V. Martin,3, E. Zucca, T. Motta, S. Cortelazzo, G. Pinotti, L. Mazzucchelli, G. Pruneri, G. Martinelli, R. Barbazza, C. Capella and F. Bertoni on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Hematological Oncology, 2007 Dec; 25(4): 184–188
Abstract (PDF) version
iels
A VIRTUAL TISSUE BANK FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS IN IMMUNOCOMPETENT INDIVIDUALS
M. Ponzoni, I. Kwee, L. Mazzucchelli, A.J.M. Ferreri, E. Zucca, C. Doglioni, F. Cavalli, F. Bertoni
Pathobiology, 2007;74(4):264-9
Abstract (PDF) version
iels
REACTIVE PERIVASCULAR T-CELL INFILTRATE PREDICTS SURVIVAL IN PRIMARY CNS B-CELL LYMPHOMAS
M. Ponzoni, F. Berger, C. Chassagne-Clement, M. Tinguely, A. Jouvet, J.M. Ferreri, S. Dell'Oro, M.R. Terreni, C. Doglioni, J. Weis, M. Cerati, M. Milani, P. Iuzzolino, T. Motta, A. Carbone, E. Pedrinis, J. Sanchez, J-Y. Blay, M. Reni, A. Conconi, F. Bertoni, E. Zucca, F. Cavalli and B. Borisch
British Journal of Haematology
2007 Aug;138(3):316-323
Abstract (PDF) version
iels
DEFINITION, DIAGNOSIS AND MANAGEMENT OF INTRAVASCULAR LYMPHOMA: PROPOSALS AND PERSPECTIVES FROM AN INTERNATIONAL CONSENSUS MEETING (LOCARNO, SWITZERLAND; DECEMBER 9-10, 2005)
M. Ponzoni, A.J.M. Ferreri, E. Campo, F. Facchetti, L. Mazzucchelli, T. Yoshino, T. Murase, S.A. Pileri, C. Doglioni, E. Zucca, F. Cavalli, and S. Nakamura
Journal of Clinical Oncology 2007 Jul20;25(21):3168-73
Abstract (PDF) version
iels
VARIATIONS IN CLINICAL PRESENTATION, FREQUENCY OF HAEMOPHAGOCYTOSIS AND CLINICAL BEHAVIOR OF INTRAVASCULAR LYMPHOMA DIAGNOSED IN DIFFERENT GEOGRAPHICAL REGIONS
A. J. M. Ferreri, G. P. Dognini, E. Campo, R. Willemze, J. F. Seymour, O. Bairey, M. Martelli, A. De Renzo, C. Doglioni, C. Montalbán, A. Tedeschi, A. Pavlovsky, S. Morgan, L. Uziel, M. Ferracci, S. Ascani, U. Gianelli, C. Patriarca, F. Facchetti, A. Dalla Libera, B. Pertoldi, B. Horvath, A. Szomor, E. Zucca, F. Cavalli, and M. Ponzoni on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Haematologica, 2007; 92(04): 486-492
Abstract (PDF) version
iels
INTRAVASCULAR LYMPHOMA: CLINICAL PRESENTATION, NATURAL HISTORY, MANAGEMENT AND PROGNOSTIC FACTORS IN A SERIES OF 38 CASES, WITH SPECIAL EMPHASIS ON THE 'CUTANEOUS VARIANT'
Ferreri AJ, Campo E, Seymour JF, Willemze R, Ilariucci F, Ambrosetti A, Zucca E, Rossi G, Lopez-Guillermo A, Pavlovsky MA, Geerts ML, Candoni A, Lestani M, Asioli S, Milani M, Piris MA, Pileri S, Facchetti F, Cavalli F, Ponzoni M; the International Extranodal Lymphoma Study Group (IELSG)
British Journal of Haematology, 2004 Oct;127(2):173-183
Abstract (PDF) version
iels
ANTRACYCLINE-BASED CHEMOTHERAPY AS PRIMARY TREATMENT FOR INTRAVASCULAR LYMPHOMA
A. J. M. Ferreri, E. Campo, A. Ambrosetti, F. Ilariucci, J. F. Seymour, R. Willemze, G. Arrigoni, G. Rossi, A. López-Guillermo, E. Berti, M. Eriksson, M. Federico, S. Cortelazzo, S. Govi, N. Frungillo, S. Dell’Oro, M. Lestani, S. Asioli, E. Pedrinis, M. Ungari, T. Motta, R. Rossi, T. Artusi, P. Iuzzolino, E. Zucca, F. Cavalli, and M. Ponzoni on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Annals of Oncology, 2004; 15(8): 1215-1221
Abstract (PDF) version
ielsg
PATHOBIOLOGY OF PRIMARY MEDIASTINAL B-CELL LYMPHOMA
Pileri SA, Zinzani PL, Gaidano G, Falini B, Gaulard P, Zucca E, Sabattini E, Ascani S, Rossi M, Cavalli F, International Extranodal Lymphoma Study Group
Leukemia and Lymphoma 2003;44 Suppl 3:S21-6
Abstract (PDF) version
ielsg
CLINICAL ACTIVITY OF RITUXIMAB IN EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA OF MALT TYPE
Annarita Conconi, Giovanni Martinelli, Catherine Thie´blemont, Andre´s J. M. Ferreri, Liliana Devizzi, Fedro Peccatori, Maurilio Ponzoni, Ennio Pedrinis, Stefania Dell’Oro, Giancarlo Pruneri, Virginio Filipazzi, Pierre-Yves Dietrich, Alessandro M. Gianni, Bertrand Coiffier, Franco Cavalli, and Emanuele Zucca
Blood 2003; 102(8): 2741-2745
Reprint (PDF) version
ielsg
NON-GASTRIC MARGINAL ZONE B-CELL LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID TISSUE
Zucca E, Conconi A, Pedrinis E, Cortelazzo S, Motta T, Gospodarowicz M, Patterson B, Ferreri A, Ponzoni M, Devizzi L, Giardini R, Pinotti G, Capella C, Zinzani P, Pileri S, Lopez-Guillermo A, Campo E, Campo E, Ambrosetti A, Baldini L & Cavalli F on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Blood 2003; 101(7): 2489-2495
Reprint (PDF) version
ielsg
PROGNOSTIC SCORING SYSTEM FOR PRIMARY CNS LYMPHOMAS: THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP EXPERIENCE
Ferreri AJM, Blay J-Y, Reni M, Pasini F, Spina M, Ambrosetti A, Calderoni A, Rossi A, Vavassori V, Conconi A, Devizzi L, Berger F, Ponzoni M, Borisch B, Tinguely M, Cerati M, Milani M, Orvieto E, Sanchez J, Chevreau Ch, Dell’Oro S, Zucca E, and Cavalli F
Journal of Clinical Oncology January 2003;21(2): 266-272
Reprint (PDF) version
ielsg
PRIMARY MEDIASTINAL B-CELL LYMPHOMA: HIGH FREQUENCY OF BCL-6 MUTATIONS AND CONSISTENT EXPRESSION OF THE TRANSCRIPTION FACTORS OCT-2, BOB.1 AND PU.1 IN THE ABSENCE OF IMMUNOGLOBULINS
Pileri SA, Gaidano G, Zinzani PL, Falini B, Gaulard P, Zucca E, Pieri F, Berra E, Sabattini E, Stefano Ascani S, Piccioli M, Johnson PWM, Giardini R, Pescarmona E, Domenico Novero D, Piccaluga PP, Marafioti T, Alonso MA, Cavalli F (on behalf of the International Extranodal Lymphoma Study Group
American Journal of Pathology January 2003; 162(1): 243-253
Reprint (PDF) version
ielsg
PATTERNS OF OUTCOME AND PROGNOSTIC FACTORS IN PRIMARY LARGE CELL LYMPHOMA OF THE TESTIS IN A SURVEY BY THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP
Zucca E, Conconi A, Mughal TI, Sarris AH, Seymour JF, Vitolo U, Klasa R, Ozsahin , Mead GM, Gianni MA, Cortelazzo S, Ferreri AJM, Ambrosetti A, Martelli M, Thiéblemont C, Gomez Moreno H, Pinotti G, Martinelli G, Mozzana R, Grisanti S, Provencio M, Balzarotti M, Laveder F, Oltean G, Callea V, Roy P, Cavalli F and Gospodarowicz MK
Journal of Clinical Oncology January 2003; 21(1): 20-27
Reprint (PDF) version
ielsg
INDUCTION CHEMOTHERAPY STATEGIES FOR PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA WITH SCLEROSIS: A RETROSPECTIVE MULTINATIONAL STUDY ON 426 PREVIOUSLY UNTREATED PATIENTS
Zinzani PL, Martelli M, Bertini M, Gianni AM, Devizzi L, Federico M, Pangalis G, Michels J, Zucca E, Cantonetti M, Cortelazzo S, Wotherspoon A, Ferreri AJM, Zaja F, Lauria F, De Renzo A, Liberati MA, Falini B, Balzarotti M, Calderoni A, Zaccaria A, Gentilini P, Fattori PP, Pavone E, Angelopoulou MK, Alinari L, Brugiatelli M, Di Renzo N, Bonifazi F, Pileri SA, Cavalli F. The International Extranodal Lymphoma Study Group (IELSG)
Haematologica 2002; 87:1258-1264
Reprint (PDF) version
IELSG
A MULTICENTER STUDY OF TREATMENT OF PRIMARY CNS LYMPHOMA
A.J.M. Ferreri, MD; M. Reni, MD; F. Pasini, MD; A. Calderoni, MD; U. Tirelli, MD; A. Pivnik, MD, PhD, DMSci; G.M. Aondio, MD; F. Ferrarese, MD; H. Gomez, MD; M. Ponzoni, MD; B. Borisch, MD; F. Berger, MD; C. Chassagne, MD; P. Iuzzolino, MD; A. Carbone, MD; J. Weis, MD; E. Pedrinis, MD; T. Motta, MD; A. Jouvet, MD; T. Barbui, MD; F. Cavalli, MD; J.-Y. Blay, MD, PhD, for the International Extranodal Lymphoma Study Group
Neurology 2002; 58(10):1513-1520
Reprint (PDF) version
ielsg
THE MODIFIED INTERNATIONAL PROGNOSTIC INDEX CAN PREDICT THE OUTCOME OF LOCALIZED PRIMARY INTESTINAL LYMPHOMA OF BOTH EXTRANODAL MARGINAL ZONE B-CELL AND DIFFUSE LARGE B-CELL HISTOLOGIES
S. Cortelazzo, A. Rossi, E. Oldani, T. Motta, R. Giardini, P. Zinzani, E. Zucca, H. Gomez, A. Ferreri, G. Pinotti, C. Chini, L. Devizzi, A. Gianni, F. Cavalli & T. Barbui on behalf of the International Extranodal Lymphoma Study Group (IELSG)
British Journal of Haematology 2002; 118(1):218-228
Reprint (PDF) version
ielsg
MOLECULAR FOLLOW-UP IN GASTRIC MALT LYMPHOMAS: PRELIMINARY RESULTS OF THE PROSPECTCIVE LY03 RANDOMISED COOPERATIVE TRIAL
F. Bertoni, A. Conconi, C. Capella, T. Motta, R. Giardini, M. Ponzoni, E. Pedrinis, D. Novero, P. Rinaldi, G. Cazzaniga, A. Biondi, A. Wotherspoon, B. Hancock, P. Smith, R. Souhami, F. Cotter, F. Cavalli & E. Zucca for the International Extranodal Lymphoma Study Group (IELSG) & the United Kingdom Lymphoma Group (UKLG)
Blood 2002; 99(7):2541-2544
Reprint (PDF) version
ielsg
RELEVANCE OF INTRAOCULAR INVOLVEMENT IN THE MANAGEMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS
Andrés J. M. Ferreri, Jean-Yves Blay, Michele Reni, Felice Pasini, Andrew Gubkin, Umberto Tirelli, Antonello Calderoni, Emanuele Zucca, Sergio Cortelazzo, Catherine Chassagne, Marianne Tinguely, Bettina Borisch, Françoise Berger, Maurilio Ponzoni, and Franco Cavalli on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Annals of Oncology 2002; 13(4):531-538
Reprint (PDF) version
ielsg
STAGE-MODIFIED INTERNATIONAL PROGNOSTIC INDEX EFFECTIVELY PREDICTS CLINICAL OUTCOME OF LOCALIZED PRIMARY GASTRIC DIFFUSE LARGE B-CELL LYMPHOMA
S. Cortelazzo, A. Rossi, E. Roggero, E. Oldani, E. Zucca, C. Tondini, A. Ambrosetti, F. Pasini, G. Pinotti, M. Bertini, U. Vitolo, M. Busetto, L. Gianni, F. Cavalli & T. Barbui for the International Extranodal Lymphoma Study Group (IELSG)
Annals of Oncology 1999; 10(12):1433-1440
Reprint (PDF) version




to top





MEETING ABSTRACTS
You can download the free Adobe Acrobat Reader to view your documents
XIII INTERNATIONAL CONFERENCE OF MALIGNANT LYMPHOMA
June 19-22, 2013 Lugano, Switzerland

Poster Presentation
IMPACT OF SURVIVAL OF MYC GENETIC ALTERATIONS BUT NOT MYD88L26P MUTATION IN PRIMARY TESTICULAR DLBCL (Abstract #159 – IELSG 10)
A. Valera, U. Vitolo, S. Epistolio, A. Riva, M. Ponzoni, P. Rafaniello Raviele, D. Novero, A. Chiappella, F. Molinari, V. Martin, A. Tucci, S. Storti, V. Pavone, H. Gomez Moreno, M. Balzarotti, G. Martinelli, M. Martelli, F. Bertoni, L. Mazzucchelli, E. Zucca
Hematol Oncol 2015; 33: 185-186

Oral presentation
ADDITIONOF THIOTEPA AND RITUXIMAB TO ANTIMETABOLITES SIGNIFICANTLY IMPROVES OUTCOME IN PRIMARY CNS LYMPHOMA: FIRST RANDOMIZATION IN THE IELSG32 TRIAL (Abstract #009 – IELSG 32)
A.J. Ferreri, K. Cwynarski, E. Pulczynski, M. Ponzoni, M. Deckert, L.S. Politi, C.P. Fox, P. LaRosée, A. Ambrosetti, A. Roth, C. Hemmaway, F. Ilariucci, K. Linton, R. Soffietti, T. Pukrop, M. Binder, M. Balzarotti, A. Fabbri, E. Schorb, P.W. Johnson, J. Sonderskov Gorlov, F. Cavalli, J. Finke, M. Reni, E. Zucca, G. Illerhaus
Hematol Oncol 2015; 33: 103-104

Oral presentation
USE OF THE LUGANO CLASSIFICATION CRITERIA FOR PET/CT ASSESSMENT OF PRIMARY MEDIASTINAL B-CELL LYMPHOMA AFTER IMMUNOCHEMOTHERAPY AND IRRADIATION IN THE IELSG-26 STUDY (Abstract #081 – IELSG 26)
L. Ceriani, M. Martelli, P. Zinzani, A.J. Ferreri, U. Vitolo, C. Stelitano, M. Gotti, M. Cabras, L. Rigacci, C. Rusconi, F. Merli, G. Pinotti, D. Mannina, S. Luminari, A. Stathis, L. Giovanella, E. Zucca, P.W. Johnson
Hematol Oncol 2015; 33: 143

Oral presentation
A SIMPLE AND EFFECTIVE MALT LYMPHOMA-SPECIFIC PROGNOSTIC INDEX GENERATED FROM THE DATASET OF THE IELSG-19 CONTROLLED CLINICAL TRIAL (Abstract #124 – IELSG 19)
C. Thieblemont, A. Conconi, D. Laszlo, A. Tucci, U. Vitolo, M. Martelli, F. Morschhauser, H. Ghesquieres, R. Pettengell, G. Pinotti, L. Devizzi, R. Bouabdallah, A. Lopez-Guillermo, A.J. Ferreri, S.A. Pileri, A. Traverse-Glehen, A. Jack, E. Campo, L. Mazzucchelli, L. Cascione, P.W. Johnson, B. Coiffier, G. Martinelli, F. Cavalli, E. Zucca
Hematol Oncol 2015; 33: 167-168

Oral presentation
THE IELSG-37 STUDY: A RANDOMIZED TRIAL ASSESSING THE ROLEOF MEDIASTINAL RADIOTHERAPY AFTER FRONT-LINE RITUXIMABAND ANTHRACYCLINE CONTAINING REGIMENS IN PATIENTS WITHPRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL)(Abstract #OT01 – IELSG 37)
M. Martelli, M. Gospodarowicz, P.W. Johnson, S. Chauvie, F. Cavalli, E. Zucca, A.J. Davies
Hematol Oncol 2015; 33: 322

ielsg
EUROPEAN HAEMATOLOGY ASSOCIATION 18th Annual Meeting
June 12-15, 2014 Milan, Italy

Oral presentation
PROGNOSTIC MODELS FOR PRIMARY MEDIASTINAL B-CELL LYMPHOMA DERIVED FROM 18-FDG PET/CT QUANTITATIVE PARAMETERS IN THE IELSG-26 STUDY
E Zucca, M. Martelli, PL Zinzani, AJM Ferreri, E. Russo, S. Montoto, A Lopez-Guillermo, AJ Davies, PWM Johnson, L Giovanella, F Cavalli, L Ceriani
(Abstract #S1346)


Poster presentation
RITUXIMAB-CHOP PLUS INTRATHECAL METHOTREXATE AND CONTRALATERAL TESTIS IRRADIATION IN UNTREATED PRIMARY TESTICULAR DIFFUSE LARGE B-CELL LYMPHOMA: LONG-TERM RESULTS OF THE IELSG-10 TRIALl
U Vitolo, A Chiappella, M Martelli, AJM Ferreri, I Baldi, M Balzarotti, C Bottelli, A Conconi, P De Masi, H Gomez, A Lopez-Guillermo, G Martinelli, F Merli, O Bairey, L Orsucci, V Pavone, U Ricardi, S Storti, MK Gospodarowicz, F Cavalli, AH Sarris, E Zucca
(Abstract P475)

ielsg
EUROPEAN HAEMATOLOGY ASSOCIATION 18th Annual Meeting
June 13-16, 2013 Stockholm, Sweden

Oral presentation
ROLE OF 18FDG-PET/CT IN POST-CHEMOTHERAPY EVALUATION OF PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA (PMLBCL): RESULTS OF AN INTERNATIONAL PHASE II TRIAL (IELSG-26 STUDY) CONDUCTED ON BEHALF OF THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG)-26 TRIAL
M Martelli, E Zucca, PL Zinzani, AJM Ferreri, U Vitolo, E Porro, C Stelitano, E Brusamolino, MG Cabras, L Rigacci, M Balzarotti, F Salvi, G Pinotti, E Russo, F Merli, C Rusconi, S Montoto, A Davies, A Di Rocco, P Paesano, A Lopez-Guillermo, F Cavalli, L Giovanella, PWM Johnson and L Ceriani
Reprint (PDF) version
ielsg
XII INTERNATIONAL CONFERENCE OF MALIGNANT LYMPHOMA
June 19-22, 2013 Lugano, Switzerland

Oral presentation
CHLORAMBUCIL PLUS RITUXIMAB PRODUCES BETTER EVENT-FREE AND PROGRESSION-FREE SURVIVAL IN COMPARISON WITH CHLORAMBUCIL OR RITUXIMAB ALONE IN EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT LYMPHOMA): FINAL RESULTS OF THE IELSG-19 STUDY
E. Zucca, A. Conconi, G. Martinelli, A. Tucci, U. Vitolo, E. Russo, B. Coiffier, H. Ghesquieres, F. Morschhauser, R. Pettengell, G. Pinotti, L. Devizzi, R. Bouabdallah, C. Copie-Bergman, S. Pileri, A. Jack, E. Campo, A. Lopez-Guillermo, P. W. Johnson, C. Thieblemont
Reprint (PDF) version

Poster presentation
MANAGEMENT AND PROGNOSIS OF PATHOLOGICAL FRACTURES IN A SERIES OF 373 PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA OF THE BONE (THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP #14 STUDY)
S. Govi, D. Christie, C. Messina, M. Bruno Ventre, E. Gracia, M. Gospodarowicz, G. Martinelli, E. Zucca, F. Cavalli, A. J. Ferreri
Reprint (PDF) version

Poster presentation
PROGNOSTIC VALUE OF 18FDG BASELINE FUNCTIONAL PET PARAMETERS IN PRIMARY MEDIASTINAL DIFFUSE LARGE B- CELL LYMPHOMA
L. Ceriani, E. Zucca, P. L. Zinzani, A. Ferreri, U. Vitolo, C. Stelitano, E. Brusamolino, G. Cabras, L. Rigacci, F. Salvi, L. Gargantini, M. Balzarotti, F. Merli, G. Pinotti, S. Montoto, A. Lopez-Guillermo, F. Cavalli, L. Giovanella, P. W. Johnson, M. Martelli
Reprint (PDF) version

Poster presentation
IELSG 34 - FINAL RESULTS OF A MULTICENTRE PHASE II STUDY TO EVALUATE THE CLINICAL ACTIVITY AND THE SAFETY OF EVEROLIMUS IN MARGINAL ZONE B-CELL LYMPHOMAS
A. Conconi, M. Raderer, S. Franceschetti, L. Devizzi, A. Ferreri, M. Magagnoli, L. Arcaini, P. L. Zinzani, G. Martinelli, U. Vitolo, E. Porro, A. Stathis, F. Cavalli, G. Gaidano, E. Zucca
Reprint (PDF) version

ielsg
AMERICAN SOCIETY OF HEMATOLOGY 54th Annual Meeting
December 8-11, 2012 Atlanta, GA

Poster presentation
ROLE OF POSITRON EMISSION TOMOGRAPHY (PET/CT) IN PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA (PMLBCL): PRELIMINARY RESULTS OF AN INTERNATIONAL PHASE II TRIAL (IELSG-26 STUDY) CONDUCTED ON BEHALF OF THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG), THE FONDAZIONE ITALIANA LINFOMI (FIL) AND THE UK NCRI LYMPHOMA GROUP
L Ceriani, E Zucca, PL Zinzani, AJM Ferreri, U Vitolo, C Stelitano, E Brusamolino, MG Cabras, L Rigacci, M Balzarotti, F Salvi, G Pinotti, E Porro, E Finolezzi, F Merli, C Rusconi, S Montoto, A Davies, P Paesano, A Lopez-Guillermo, F Cavalli, L Giovanella, P Johnson and M Martelli

Reprint (PDF) version
ielsg
EUROPEAN HAEMATOLOGY ASSOCIATION 17th Annual Meeting
June 14-17, 2012 Amsterdam, The Netherlands

Oral presentation
CHLAMYDOPHILA PSITTACI ERADICATION WITH DOXYCYCLINE IS AN ACTIVE FIRST-LINE TARGETED THERAPY FOR OCULAR ADNEXAE LYM- PHOMA: FINAL RESULTS OF AN INTERNATIONAL PHASE II PROSPECTI- VE STUDY (IELSG#27 TRIAL)
S. Govi, E. Pasini, S. Mappa, F. Bertoni, F. Zaja, C. Montalbán, C. Stelitano, M.E. Cabrera, A.G. Resti, L.S. Politi, C. Doglioni, F. Cavalli, E. Zucca, L. Spagnuolo, M. Ponzoni, R. Dolcetti and A.J.M. Ferreri on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Reprint (PDF) version
ielsg
AMERICAN SOCIETY OF HEMATOLOGY 53th Annual Meeting
December 10-13, 2011 San Diego, CA

Oral presentation
FINAL RESULTS OF A MULTICENTER PHASE II TRIAL WITH TRANSLATIONAL ELEMENTS TO INVESTIGATE THE POSSIBLE INFECTIVE CAUSES OF OCULAR ADNEXAL MARGINAL ZONE B-CELL LYMPHOMA (OAMZL) WITH PARTICULAR REFERENCE TO CHLAMYDIA SPECIES AND THE EFFICACY OF DOXYCYCLINE AS FIRST-LINE LYMPHOMA TREATMENT (THE IELSG#27 TRIAL)
S. Govi, R. Dolcetti, M. Ponzoni, E. Pasini, S. Mappa, M. Bruno Ventre, C. Doglioni, F. Bertoni, F. Zaja, C. Montalban, C. Stelitano, M.E. Cabrera, F. Cavalli, E. Zucca and A.J.M. Ferreri

Reprint (PDF) version

Oral presentation

POTENTIAL PATHOGENETIC ROLE OF ACHROMOBACTER (ALCALIGENES) XYLOSOXIDANS IN PRIMARY EXTRANODAL MARGINAL ZONE LYMPHOMA OF THE LUNG (BALT-LYMPHOMA): UPDATE OF THE RESULTS OF A RETROSPECTIVE ANALYSIS ON BEHALF OF IELSG
S Sammassimo, G Pruneri, P Adam, SA. Pileri, P Rafaniello, S Steffanoni, S Gandini, M Negri, TM Habermann, Z-M Li, PL Zinzani, M Raderer, JO Armitage, DD Weisenburger, O Bairey, M Cabrera, E Zucca, B Puccini, G Gutierrez-Garcia, EK Warzocha, A Carpaneto, C Besson, E Porro, F Cavalli, GS Nowakowski,and G Martinelli

Reprint (PDF) version
ielsg
ITALIAN SOCIETY OF HEMATOLOGY 43th National Congress
October 16-19, 2011 Napoli, Italy

Oral presentation
CLINICAL VARIABLES WITH PROGNOSTIC RELEVANCE IN MALT LYMPHOMA PATIENTS TREATED IN THE IELSG 19 INTERNATIONAL MULTICENTER RANDOMISED STUDY
Conconi A, Thieblemont C, Laszlo D, Torri V, Bouabdallah R, Tucci A, Vitolo U, Martelli M, Coiffier B, Sebban C, Floriani I, Johnson P, Guillermo AL, Martinelli G, Zucca E
Reprint (PDF) version
ielsg
XI INTERNATIONAL CONFERENCE OF MALIGNANT LYMPHOMA
June 15-18, 2011 Lugano, Switzerland

Oral presentation
PET/CT RESPONSE ANALYSIS IN PRIMARY MEDIASTINAL DIFFUSE LARGE B-CELL LYMPHOMA (PMBL): PRELIMINARY RESULTS OF THE IELSG-26 STUDY
M. Martelli, L. Ceriani, P.L. Zinzani, S. Govi, C. Stelitano, U. Vitolo, E. Brusamolino, G. Cabras, L. Rigacci, M. Balzarotti, F. Salvi, S. Montoto, A. Lopez-Guillermo, E. Zucca, L. Giovanella, P.W.M. Johnson
Reprint (PDF) version

Poster presentation
ANALYSIS OF PROGNOSTIC FACTORS IN 424 MALT LYMPHOMA PATIENTS TREATED IN THE IELSG-19 MULTICENTER RANDOMISED STUDY
A. Conconi, C. Thieblemont, D. Laszlo, V. Torri, R. Bouabdallah, A. Tucci, U. Vitolo, M. Martelli, B. Coiffier, C. Sebban, I. Floriani, P. Johnson, A. Lopez Guillermo, E. Porro, G. Martinelli, E. Zucca

Reprint (PDF) version

Poster presentation
A PHASE II STUDY TO INVESTIGATE THE PREVALENCE OF INFECTIOUS AGENTS IN OCULAR ADNEXAE MARGINAL ZONE LYMPHOMA (OAMZL) AND THE EFFICACY OF ANTI- BIOTIC THERAPY (IELSG-27 TRIAL)
S. Govi, R. Dolcetti, M. Ponzoni, E. Pasini, S. Mappa, C. Doglioni, F. Bertoni, F. Zaja, C. Montalban, C. Stelitano, M. E. Cabrera, F. Cavalli, E. Zucca, A. J. Ferreri

Reprint (PDF) version

ielsg
AMERICAN SOCIETY OF HEMATOLOGY 52th Annual Meeting
December 4-7, 2010 Orlando, FL

Oral and poster presentation
CHLORAMBUCIL PLUS RITUXIMAB PRODUCES BETTER EVENT-FREE SURVIVAL IN COMPARISON WITH CHLORAMBUCIL ALONE IN THE TREATMENT OF MALT LYMPHOMA: 5-YEAR ANALYSIS OF THE 2-ARMS PART OF THE IELSG-19 RANDOMIZED STUDY
Emanuele Zucca, Annarita Conconi, Giovanni Martinelli, Maurizio Martelli, Catherine Thieblemont, Peter W Johnson, Armando Lopez-Guillermo, Reda Bouabdallah, Alessandra Tucci, Umberto Vitolo, Bertrand Coiffier, Liliana Devizzi, Fabrice Jardin, Catherine Sebban, Graziella Pinotti, Franck Morschhauser, Ruth Pettengell, Andre Bosly, Emili Montserrat, Monica Bellei, Stefano A. Pileri, Christiane Copie-Bergman, Elias Campo, Andrew Jack, Luca Mazzucchelli and Franco Cavalli

Reprint (PDF) version

Oral and poster presentation

PRIMARY EXTRANODAL MARGINAL ZONE LYMPHOMA OF THE LUNG (BALT-LYMPHOMA): RESULTS OF A RETROSPECTIVE ANALYSIS ON BEHALF OF IELSG
Simona Sammassimo, Giancarlo Pruneri, Stefano A. Pileri, Paola Rafaniello, Sara Steffanoni, Sara Gandini, Mara Negri, Pier Luigi Zinzani, Markus Raderer, Patrick Adam, James O. Armitage, Dennis D. Weisenburger, Osnat Bairey, Maria Cabrera, Emanuele Zucca, Luigi Rigacci, Gonzalo Gutierrez-Garcia, Andrea Carpaneto, Caroline Besson, Ewa Kalinka Warzocha, Franco Cavalli and Giovanni Martinelli

Reprint (PDF) version
ielsg
AMERICAN SOCIETY OF HEMATOLOGY 51th Annual Meeting
December 5-8, 2009 New Orleans, LA

Poster presentation
INTERIM ANALYSIS OF THE IELSG-19 RANDOMISED STUDY OF CHLORAMBUCIL ALONE VERSUS CHLORAMBUCIL PLUS RITUXIMAB VERSUS RITUXIMAB ALONE IN EXTRANODAL MARGINAL ZONE LYMPHOMAS OF MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT LYMPHOMA)
Emanuele Zucca, Annarita Conconi, Maurizio Martelli, Catherine Thieblemont, Peter Johnson, Armando Lopez Guillermo, Reda Bouabdallah, Alessandra Tucci, Umberto Vitolo, Bertrand Coiffier, Liliana Devizzi, Fabrice Jardin, Catherine Sebban, Graziella Pinotti, Franck Morschhauser, Ruth Pettengell, André Bosly, Emilio Montserrat, Monica Bellei, Stefano A. Pileri, Christiane Copie-Bergman, Elias Campo, Andrew Jack, Luca Mazzucchelli, Irene Floriani, Daniela Garavaglia, Valter Torri, Franco Cavalli, and Giovanni Martinelli

Reprint (PDF) version
ielsg
ITALIAN SOCIETY OF HEMATOLOGY 42th National Congress
October 18-21, 2009 Milan, Italy

Poster presentation
TREATMENT, PROGNOSTIC FACTORS AND BIOLOGICAL CHARACTERISTICS OF PRIMARY THYROID B-CELL LYMPHOMAS (PTL): AN IELSG AND IIL STUDY
Mian M., Cortelazzo S., Gaidano G., Conconi A., Tsang R., Gospodarowicz M.K., Rambaldi A., Rossi A., Oldani E.4, Federico M., Luminari S., Bellei M., Pogliani E., Rossini F., Cabrera M.E., Garcia H., Pena K., Martelli M., Lopez-Guillermo A., Busetto M., Cavalli F., Zucca E.
Reprint (PDF) version
ielsg
EUROPEAN HAEMATOLOGY ASSOCIATION 14th Annual Meeting
June 4-7, 2009 Berlin, Germany

Oral presentation
SINGLE AGENT BORTEZOMIB IS ACTIVE IN RELAPSED/REFRACTORY
MALT LYMPHOMAS. FINALRESULTS OF AN INTERNATIODALLYMPHOMASTUDY GROUP (IELSG) PHASE II STUDY
A Conconi, G Martinelli, A Lopez-Guillermo, PL Zinzani, AJM Ferreri, L Rigacci, L Devizzi, U Vitolo, S Luminari, M Martelli, F Cavalli, E Zucca

Reprint (PDF) version

Poster presentation
CLIPI: ANEW PROGNOSTIC INDEX FOR INDOLENT CUTANEOUS B-CELL
LYMPHOMAPROPOSED BY THE INTERNATIONALEXTRANODALLYM-
PHOMASTUDY GROUP (IELSG 11)
M. Mian, S. Cortelazzo, M. Federico, S. Luminari, L. Marcheselli, M. Cantonetti, AH. Sarris, A. Rossi, A. Rambaldi, G. Lombardo, M. Frontoni, F. Pasini, L. Devizzi, O. Bairey, M. Busetto, E. Berti, G. Martinelli, R. Tsang, S. Rudoy, R. Blum, A. Ferreri, G. Pinotti, E. Pogliani and E. Zucca

Reprint (PDF) version
ielsg

AMERICAN SOCIETY OF HEMATOLOGY 50th Annual Meeting
December 6-9, 2008 San Francisco, California

Oral presentation
RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE ALONE OR ASSOCIATED WITH HIGH-DOSE CYTARABINE FOR PATIENTS WITH PRIMARY CNS LYMPHOMA (IELSG #20 TRIAL): TOLERABILITY, ACTIVITY AND EVENT-FREE SURVIVAL ANALYSIS

AJM Ferreri, M Reni, M Foppoli, M Martelli, M Siakantaris, M Frezzato, MG Cabras, A Fabbri, G Corazzelli, F Ilariucci, G Rossi, R Soffietti, C Stelitano, D Vallisa, F Zaja, M Gelemur, GM Aondio, G Avvisati, M Balzarotti, A Brandes, MJ Costa, H Gomez, A Guarini, G Pinotti, L Rigacci, C Uhlmann, M Angelopoulou, M Tirindelli, V Naso, A Franzin, N Anzalone, M Ponzoni, E Zucca, F Caligaris-Cappio and F Cavalli

Reprint (PDF) version

Poster presentation
THE IMPACT OF THERAPEUTIC MANAGEMENT AND PROGNOSTIC FACTORS, ON THE OUTCOME OF PRIMARY CUTANEOUS B-CELL LYMPHOMAS (PCBCL) - IELSG 11 STUDY

S Cortelazzo, M Mian, M Cantonetti, AH Sarris, A Rossi, A Rambaldi, G Lombardo, M Frontoni, F Pasini, A Ambrosetti, L Devizzi, M Busetto, O Bairey, E Berti, G Martinelli, R Tsang, S Rudoy, R Blum, A Ferreri, G Pinotti, E Pogliani and E Zucca

Reprint (PDF) version

ielsg
EUROPEAN ASSOCIATION FOR HAEMATOPATHOLOGY 14th Annual Meeting
September 21-27, 2008 Bordeaux, France

Poster presentation
PRIMARY BONE MARROW LYMPHOMAS (PBML): CLINICAL PRESENTATION, HISTOPATHOLOGICAL FEATURES AND OUTCOME (IELSG #29)
M. Rozman, A. Martínez, C. Agostinelli, K. M. Hebeda, E. Matutes, M. Ponzoni, A. Ferreri, C. Campidelli, B. Espinet, G. Perea, A. Acevedo, S. Pileri, A. López-Guillermo, E.
Campo, on behalf of the International Extranodal Lymphoma Study Group
Reprint (PDF) version
ielsg
EUROPEAN HAEMATOLOGY ASSOCIATION 13th Annual Meeting
June 12-15, 2008 Copenhagen, Denmark

Oral presentation
RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY (CHT) WITH HIGH-DOSE METHOTREXATE (MTX) ALONE OR ASSOCIATED WITH HIGH-DOSE CYTARABINE (ARAC) FOR PATIENTS (PTS) WITH PRIMARY CNS LYMPHOMA (PCNSL)
AJ Ferreri, M Foppoli, M Martelli, G Pangalis, M Frezzato, G Cabras, A Fabbri, G Corazzelli, F Ilariucci, G Rossi, R Soffietti, C Stelitano, D Vallisa, F Zaja, L Zoppegno, G Aondio, O Annibali, M Balzarotti, A Brandes, J Fajardo, H Gómez, A Guarini, G Pinotti, L Rigacci, C Uhlmann, M Ponzoni, M Reni, E Zucca, F Cavalli on behalf of the International Extranodal Lymphoma Study Group

Reprint (PDF) version

Oral presentation
PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE TESTIS: IMPROVED _OUTCOME WITH RITUXIMAB-CHOP WITH CNS AND CONTRALATERAL TESTIS _PROPHYLAXIS. FINAL RESULTS OF IELSG 10 STUDY
U Vitolo, E Zucca, M Martelli, A Chiappella, M Balzarotti, G Benevolo, P De Masi, A Filippi, MK Gospodarowicz, A Lopez-Guillermo, G Martinelli, F Merli, T Perrone, P Pregno, AH Sarris, S Storti and F Cavalli on the behalf of IELSG and IIL
Reprint (PDF) version

Poster presentation
PRIMARY EXTRANODAL FOLLICULAR LYMPHOMA OF HEAD AND NECK (PEFLHN): A RARE DISEASE WITH A POOR CLINICAL OUTCOME (IELSG 23)
S Cortelazzo, M Mian, R Tsang, A Rossi, ME Cabrera, M Federico, E Zucca, M Busetto, A Rambaldi, and F Cavalli, on behalf of IELSG and IIL
Reprint (PDF) version
ielsg
X INTERNATIONAL CONFERENCE OF MALIGNANT LYMPHOMA
June 4-7, 2008 Lugano, Switzerland

Oral presentation
RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY (CHT) WITH HIGH-DOSE METHOTREXATE (MTX) ALONE OR ASSOCIATED WITH HIGH-DOSE CYTARABINE (ARAC) FOR PATIENTS (PTS) WITH PRIMARY CNS LYMPHOMA (PCNSL)
AJ Ferreri, M Foppoli, M Martelli, G Pangalis, M Frezzato, G Cabras, A Fabbri, G Corazzelli, F Ilariucci, G Rossi, R Soffietti, C Stelitano, D Vallisa, F Zaja, L Zoppegno, G Aondio, O Annibali, M Balzarotti, A Brandes, J Fajardo, H Gómez, A Guarini, G Pinotti, L Rigacci, C Uhlmann, M Ponzoni, M Reni, E Zucca, F Cavalli International Extranodal Lymphoma Study Group (IELSG), Switzerland
Reprint (PDF) version

Oral presentation
RITUXIMAB(R) CHOP WITH CNS AND CONTRALATERAL TESTIS PROPHYLAXIS IMPROVES THE OUTCOME OF PRIMARY TESTICULAR LYMPHOMA(PTL): FINAL RESULTS OF IELSG10 STUDY
U Vitolo, E Zucca, A Chiappella, M Balzarotti, C Bottelli, A Conconi, P De Masi, H Gomez, A Lopez-Guillermo, M Martelli, G Martinelli, F Merli, V Naso, L Orsucci, V Pavone, V Secondo, S Storti, M Gospodarowicz, A Sarris, F Cavalli, on behalf of International Extranodal Lymphoma Study Group (IELSG)

Reprint (PDF) version

Poster presentation
RITUXIMAB IMPROVES OUTCOME IN WESTERN PATIENTS WITH INTRAVASCULAR LARGE B-CELL LYMPHOMA (IVL)
GP Dognini, M Ponzoni, O Bairey, C Montalbàn, A Szomor, L Uziel, J Seymour, A Ambrosetti, M Martelli, G Rossi, M Federico, A Candoni, A De Renzo, M Piris, E Zucca, C Doglioni, AJ Ferreri on behalf of the International Extranodal Lymphoma Study Group (IELSG)

Reprint (PDF) version

Poster presentation
INTRAVASCULAR LARGE B-CELL LYMPHOMA(IVLBCL): INTERNATIONAL CONSENSUS ON DIAGNOSTIC AND THERAPEUTIC ISSUES
M Ponzoni, AJ Ferreri, E Campo, GP Dognini, F Facchetti, T Kinoshita, L Mazzucchelli, T Yoshino, T Murase, M Seto, K Shimada, SA Pileri, C Doglioni, E Zucca, F Cavalli, S Nakamura, on Behalf of International Intravascular Lymphoma Study Group
Reprint (PDF) version

Poster presentation
ACTIVITY OF BORTEZOMIB IN MALT LYMPHOMAS: A IELSG PHASE II STUDY
A Conconi, A Lopez-Guillermo, G Martinelli, L Rigacci, U Vitolo, PL Zinzani, A Ferreri, S Luminari, M Martelli, F Cavalli, E Zucca

Reprint (PDF) version

ielsg

AMERICAN SOCIETY OF HEMATOLOGY 49th Annual Meeting
December 8-11, 2007 Atlanta, Georgia

Poster presentation
IELSG PHASE II STUDIES OF BORTEZOMIB IN MALT LYMPHOMAS

A Conconi, A Lopez-Guillermo, G Martinelli, L Rigacci, U Vitolo, PL Zinzani, S Luminari, F Cavalli, E Zucca

Reprint (PDF) version

Poster presentation
PRIMARY THYROID LYMPHOMA: A RETROSPECTIVE IELSG AND IIL ANALYSIS OF CLINICAL CHARACTERISTICS, PROGNOSTIC FACTORS, TREATMENT OUTCOME AND SOMATIC HYPERMUTATION FOR LOCALIZED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

S Cortelazzo, G Gaidano, M Mian, A Conconi, A Rossi, M E Cabrera, M Federico, M Bellei, S Magrini, M Martelli, H Gomez, A Lopez-Guillermo, E M Pogliani, F Rossini, M Busetto, C Visco, R Tsang, E Zucca, A Rambaldi, F Cavalli

Reprint (PDF) version

ielsg
EUROPEAN HAEMATOLOGY ASSOCIATION 12th Annual Meeting
June 7-10, 2007 Vienna, Austria

Oral presentation
PRIMARY EXTRANODAL DIFFUSE LARGE B-CELL LYMPHOMAS (DLBCL) ARISING IN DISTINCT SITES OF HEAD AND NECK HAVE DIFFERENT CLINICAL CHARACTERISTICS AND OUTCOME
S Cortelazzo, M Mian, A Rossi, E Oldani, ME Cabrera, M Federico, M Bellei, S Magrini, M Buglione, M Martelli, H Gomez, A Lopez-Guillermo, E Pogliani, F Rossini, G Gaidano, A Conconi, M Busetto, AM Scattolin, C Visco, R Tsang, E Zucca, A Rambaldi and F Cavalli on behalf of IELSG and IIL
Reprint (PDF) version

Poster presentation
PATTERNS OF OUTCOME AND PROGNOSTIC FACTORS IN PRIMARY BONE LYMPHOMA(OSTEOLYMPHOMA): A SURVEY OF 499 CASES BY THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP
D Christie, E Gracia, M Gospodarowicz, G Martinelli, K Dear, E Taylor, A Ferreri, Y Park, D Heo, D Porter, J Radford, H Lucraft, J Jayamohan, N Pavlakis, A Hong, V Ballova, C Visco , B Pro, E Zucca
Reprint (PDF) version
ielsg

AMERICAN SOCIETY OF HEMATOLOGY 48th Annual Meeting
December 9-12, 2006 Orlando, Florida

Oral communication
PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF THE TESTIS (PTL): A PROSPECTIVE STUDY OF RITUXIMAB (R)-CHOP WITH CNS AND CONTRALATERAL TESTIS PROPHYLAXIS. RESULTS OF THE IELSG 10 STUDY

U Vitolo, E Zucca, M Martelli, A Chiappella, I Baldi, M Balzarotti, A Conconi, H Gomez, A Lopez-Guillermo, G Martinelli, L Orsucci, V Pavone, G Rossi, S Storti, M K Gospodarowicz, F Cavalli and A H Sarris on behalf of International Extranodal Lymphoma Study Group (IELSG)

Reprint (PDF) version

Poster presentation
PROSPECTIVE MANAGEMENT OF PRIMARY TESTICULAR LYMPHOMA (PTL) WITH DOXORUBICIN-BASED CHEMOTHERAPY, PROPHYLACTIC INTRATHECAL (IT) METHOTREXATE AND RADIOTHERAPY (RT), BUT WITHOUT RITUXIMAB: RESULTS FROM IELSG

A H Sarris, U Vitolo, E Zucca, G Z Rassidakis, J Medeiros, M G Cabras, A Di Rocco, B Pro, M K Gospodarowicz and F Cavalli on behalf of International Extranodal Lymphoma Study Group (IELSG)

Reprint (PDF) version

ielsg
EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY 31st Annual Meeting
29-9 / 3-10, 2006 Istanbul, Turkey

Poster presentation
ONCOLOGY PREVALENCE OF HEPATITIS C VIRUS AND GB-C VIRUS INFECTION AMONG PATIENTS WITH B-CELL NON-HODGKIN'S LYMPHOMA: A CASE-CONTROL STUDY OF THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP

S Guidicelli-Nicolosi, D Rodriguez-Abreu, A Conconi, S Grisanti, A Lopez-Guillermo, P W Johnson, E Montserrat, F Cavalli, J C Piffaretti, E Zucca

Reprint (PDF) version
ielsg
EUROPEAN HAEMATOLOGY ASSOCIATION 11th Annual Meeting
June 15-18, 2006 Amsterdam, the Netherlands

Poster presentation
CLINICAL FEATURES OF THE WESTERN AND ASIAN FORMS OF INTRAVASCULAR LYMPHOMA (IVL) VARIES ACCORDING TO THE PRESENCE OF HEMOPHAGOCYTIC SYNDROME (HPS) AND NOT TO THE GEOGRAPHICAL AREA (IELSG 17)
A.J.M. Ferreri, G.P. Dognini, E. Campo, E. Zucca, M. Martelli, A. De Renzo, C. Doglioni, M. Ferracci, C. Montalban, A. Tedeschi, A. Pavlovsky, A. Morgan, L. Uziel, S. Ascani, U. Gianelli, C. Patriarca, F. Facchetti, L. Mazzucchelli, F. Cavalli, M. Ponzoni
Reprint (PDF) version
ielsg
AMERICAN SOCIETY OF HEMATOLOGY 47th Annual Meeting
December 10-13, 2005 Atlanta, Georgia

Poster presentation
THE STAGE-MODIFIED IPI (MIPI), HISTOLOGY AND A COMBINED TREATMENT INFLUENCE THE CLINICAL OUTCOME OF 401 PATIENTS WITH PRIMARY EXTRANODAL HEAD AND NECK B-CELL LYMPHOMAS (PHNBCL) (IELSG 23)
Sergio Cortelazzo, MD, Andrea Rossi, MD, Massimo Federico, MD, Andrea
Peveri, MD, Stefano Magrini, MD, Maurizio Martelli, MD, Armando Lopez
Guillermo, MD, Elena Oldani, BSc, Alessandro Rambaldi, MD, Fausto Rossini,
MD, Enrico M. Pogliani, MD, Emanuele Zucca, MD, Annarita Conconi, MD,
Mario Busetto, MD, Gianluca Gaidano, MD, Tiziano Barbui, MD and Franco
Cavalli, MD

Reprint (PDF) version
ielsg
ITALIAN SOCIETY OF HEMATOLOGY 40th National Congress
July 3-6, 2005 Bergamo, Italy

Oral presentation
THE MODIFIED INTERNATIONAL PROGNOSTIC INDEX (MIPI] PREDICTS THE CLINICAL OUTCOME OF 416 PATIENTS WITH PRIMARY EXTRANODAL HEAD AND NECK NON-HODGKIN'S LYMPHOMA
Cortelazzo S, Rossi A, Federico M, Peveri A, Martelli M, Lopez Guillermo A, Oldani E, Rossini F, Zucca E, Conconi A.R, Busetto M, Gaidano G, Barbui T, and Cavalli F, on behalf of IELSG and IIL
Reprint (PDF) version
ielsg
IX INTERNATIONAL CONFERENCE OF MALIGNANT LYMPHOMA
June 8-11, 2005 Lugano, Switzerland

Oral presentation
CHLORAMBUCIL VERSUS OBSERVATION AFTER ANTI-HELICOBACTER THERAPY IN LOW-GRADE GASTRIC LYMPHOMA: RESULTS OF THE INTERNATIONAL LY03 TRIAL” B. Hancock , D. Linch, J. Delchier, W. Qian, P. Smith, A. Wotherspoon , C. Copie-Bergmann, C. Traulle, S. Cortellazzo, A. Ferreri , A. Ambrosetti, G. Pinotti, F. Cavalli, R. Souhami, E. Zucca
Reprint (PDF) version

Poster presentation

CHROMOSOME 11Q21 -> TER GENE EXPRESSION IN DIFFUSE LARGE B CELL LYMPHOMAS (DLBCL)
A. Rinaldi , A. M. Chiaravalli, I. Kwee, E. Zucca, M. G. Tibiletti, C. Catapano, C. Capella, F. Bertoni
Reprint (PDF) version

Poster presentation

VALIDATION OF THE GELA SCORING SYSTEM FOR EVALUATING GASTRIC BIOPSIES FROM PATIENTS WITH MALT LYMPHOMA FOLLOWING ERADICATION OF HELICOBACTERPYLORI”
C. Copie-Bergman, C. Capella, T. Motta, E. Pedrinis, S. Pileri, M. Ponzoni, F. Bertoni, A. Conconi, E. Zucca, A. Wotherspoon

Reprint (PDF) version

Abstract presentation

LOW RATE OF CNS RECURRENCE IN A COHORT OF 309 PRIMARY EXTRANODAL HEAD AND NECK DIFFUSE LARGE BCELL LYMPHOMA (HN-DLBCL) (IELSG 23)
S. Cortelazzo, A. Rossi, M. Federico, A. Peveri, M. Martelli, A.Lopez Guillermo, E. Oldani, F. Rossini, E. Zucca, A. Conconi, T. Barbui, F. Cavallli

Reprint (PDF) version

Poster presentation
PRIMARY EFFUSION LYMPHOMA(PEL): ARETROSPECTIVE IELSG STUDY
A. Conconi, M. Spina, V. Ascoli, A. Lopez-Guillermo, S. Cortelazzo, A. Re, R. Ichinohasama, T. Sata, M. Luppi, D. Vallisa, C. Bergonzi, M. Provencio, D. Rossi, A. Levine, M. Raphael, A. Klepfish, A. Gloghini, S. Prevot, G. Gaidano,
A. Carbone
Reprint (PDF) version

ielsg
EUROPEAN HAEMATOLOGY ASSOCIATION 10th Annual Meeting
June 2-5, 2005 Stockholm, Sweden

Oral presentation
THERAPEUTIC MANAGEMENT, PROGNOSTIC FACTORS AND CLINICAL OUTCOME OF 416 PATIENTS WITH PRIMARY EXTRANODAL HEAD AND NECK NON-HODGKIN’S LYMPHOMA (IELSG 23)
S.Cortelazzo, A. Rossi, M.Federico, A. Peveri, M.Martelli, A.Lopez Guillermo, E. Oldani, F.Rossini. E. Zucca, A.R. Conconi, M. Busetto, G.Gaidano, T. Barbui and F.Cavalli, on behalf of IELSG and IIL
Reprint (PDF) version
ielsg
AMERICAN SOCIETY OF CLINICAL ONCOLOGY 41st Annual Meeting
May 13-17, 2005 Orlando, Florida

Poster presentation
PRIMARY NON-HODGKIN'S LYMPHOMAOF THE BREAST: FIRST REPORT OF THE MULTICENTRE RETROSPECTIVE STUDY OF THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG-15)

G. F. Ryan, G. Martinelli, K. Yuen, J. Seymour, International Extranodal Lymphoma Study Group

Reprint (PDF) version
ielsg
AMERICAN SOCIETY OF HEMATOLOGY 46th Annual Meeting
December 4-7, 2004 San Diego, California

Poster presentation
AN IELSG INTERNATIONAL SURVEY OF PRIMARY EFFUSION LYMPHOMA (PEL)
A. Conconi, M. Spina, V. Ascoli, A. Lopez-Guillermo, S. Cortelazzo, A. Re, R. Ichinohasama, T. Sata, M. Luppi, D. Vallisa, C. Bergonzi, M. Provencio, D. Rossi, A. Levine, M. Raphael, A. Klepfish, A. Gloghini, S. Prevot, G. Gaidano, A. Carbone

Reprint (PDF) version
ielsg
EIGHT INTERNATIONAL CONFERENCE OF MALIGNANT LYMPHOMA
June 12-15, 2002 Lugano, Switzerland

Oral communication
CLINICAL PRESENTATION, MANAGEMENT AND PROGNOSIS OF INTRAVASCULAR LYMPHOMATOSIS (IVL): AN ONGOING CLINICO-PATHOLOGIC STUDY OF THE I.E.L.S.G. (IELSG #17 STUDY)
A.J.M. Ferreri, J.F. Seymour, S. Grisanti, G. Rossi, E. Berti, M.A. Pavlovsky, M. Martelli, S. Govi, M. Ungari, S. Ascani, S. Pileri, E. Pedrinis, C. Patriarca, G. Arrigoni, F. Facchetti, F. Cavalli, and M. Ponzoni on behalf of the International Extranodal Lymphoma Study Group (I.E.L.S.G.)
Reprint (PDF) version

Oral communication
MEDIASTINAL SCLEROSING LARGE B-CELL LYMPHOMA. AN OVERVIEW BASED ON THE RESULTS OF A PATHOLOGIC TRIAL SUPPORTED BY THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG)
Stefano A. Pileri, Gianluca Gaidano, Pier Luigi Zinzani, Brunangelo Falini, Philippe Gaulard, Emanuele Zucca, Federica Pieri, Claudia Valli, Eva Berra, Elena Sabattini, Stefano Ascani, Milena Piccioli, Peter Johnson, Roberto Giardini, Edoardo Pescarmona, Domenico Novero, Pier Paolo Piccaluga, Teresa Marafioti, Miguel A. Alonso, Franco Cavalli. On the IELSG behalf

Reprint (PDF) version

Poster presentation

IELSG PHASE II STUDY OF RITUXIMAB IN MALT LYMPHOMAS: FINAL RESULTS
Conconi A, Thieblemont C, Martinelli G, Ferreri A, Devizzi L, Peccatori F, Ponzoni M, Filipazzi V, Dietrich PY, Gianni M, Coiffier B, Cavalli F, Zucca E on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Reprint (PDF) version

Poster presentation

REACTIVE PERIVASCULAR T-CELL INFILTRATE IS AN INDEPENDENT FAVORABLE PROGNOSTIC FACTOR IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS (PCNSL) IN IMMUNOCOMPETENT PATIENTS

M. Ponzoni , F. Berger, C. Chassagne-Clement, M. Tinguely, A. Jouvet, P. Iuzzolino, M. Cerati, A. Carbone, J. Weis, T. Motta, E. Pedrinis, M. Milani, E. Orvieto, J. Sanchez,, J-Y Blay, A. Ambrosetti, M. Reni, V. Vavassori, M. Spina, A. Calderoni, S. Cortelazzo, A. Conconi, E. Zucca, G. Aondio, F. Ferrarese, H. Gomez, A.J.M. Ferreri, F. Cavalli and B. Borisch on behalf of International Extranodal Lymphoma Study Group (IELSG)

Reprint (PDF) version

ielsg
AMERICAN SOCIETY OF CLINICAL ONCOLOGY 38th Annual Meeting
May 18-21, 2002 Orlando, Florida

Poster presentation
IELSG PHASE II STUDY OF RITUXIMAB IN MALT LYMPHOMAS: FINAL RESULTS
Conconi A, Thieblemont C, Martinelli G, Ferreri A, Devizzi L, Peccatori F, Ponzoni M, Filipazzi V, Dietrich PY, Gianni M, Coiffier B, Cavalli F, Zucca E on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Reprint (PDF) version
ielsg

AMERICAN SOCIETY OF HEMATOLOGY 43rd Annual Meeting
December 7-11, 2001 Orlando, Florida

Oral communication
GASTRIC MALT LYMPHOMAS PROSPECTCIVE LY03 RANDOMISED COOPERATIVE TRIAL: PRELIMINARY RESULTS OF THE MOLECULAR FOLLOW-UP
F. Bertoni, A. Conconi, C. Capella, T. Motta, R. Giardini, M. Ponzoni, E. Pedrinis, D. Novero, P. Rinaldi, G. Cazzaniga, A. Biondi, A. Wotherspoon, B.W. Hancock, P. Smith, R. Souhami, F.E. Cotter, F. Cavalli and E. Zucca, on behalf of the International Extranodal Lymphoma Study Group (IELSG) and the United Kingdom Lymphoma Group (UKLG)
Reprint (PDF) version

Oral communication
ACTIVITY OF RITUXIMAB IN EXTRANODAL MARGINAL ZONE LYMPHOMAS (MZL)
Conconi A, Thieblemont C, Martinelli G, Ferreri A, Devizzi L, Peccatori F, Ponzoni M, Filipazzi V, Dietrich PY, Gianni M, Coiffier B, Cavalli F, Zucca E on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Reprint (PDF) version

Poster presentation
PROGNOSTIC SCORING SYSTEM FOR PRIMARY CUTANEOUS B-CELL LYMPHOMA (PCBCL)
S. Cortelazzo, T. Motta, A. Rossi, E. Oldani, L. Devizzi, M. Busetto, A. Ferreri, G. Martinelli, M.H. Prince, G. Pinotti, A. Conconi, F. Cavalli, T. Barbui
Reprint (PDF) version

ielsg
FIRST WORLD CONGRESS OF NEURO-ONCOLOGY 2001

Oral communication
PROGNOSTIC SCORING SYSTEM FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS (PCNSL): THE I.E.L.S.G. PROPOSAL
A.J.M. Ferreri, J-Y. Blay, A. Calderoni, A. Ambrosetti, U. Tirelli, S. Cortelazzo, A. Gubkin, E. Zucca, H. Gomez, E. Orvieto, B. Borisch, F. Berger, A. Jouvet, M. Tingueli, C. Chassagne, M. Ponzoni, and M. Reni on behalf of the International Extranodal Lymphoma Study Group (I.E.L.S.G.)

Reprint (PDF) version
ielsg
EUROPEAN CANCER CONFERENCE 11th Meeting
October 21-25, 2001 Lisbon, Portugal

Poster presentation
I.E.L.S.G. PROGNOSTIC SCORE FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS (PCNSL): ANALYSIS OF AN INTERNATIONAL SERIES OF 378 IMMUNOCOMPETENT PATIENTS
A. J. M. Ferreri, M. Reni, F. Pasini, M. Spina, A. Calderoni, A. Rossi, A. Conconi, A. Pivnik, F. Cavalli, and J-Y. Blay, on behalf of the International Extranodal Lymphoma Study Group (I.E.L.S.G.)

Reprint (PDF) version
ielsg
EUROPEAN HAEMATOLOGY ASSOCIATION 6th Annual Meeting
June 21-24, 2001 Frankfurt, Germany

Poster presentation
TREATMENT OF EXTRANODAL MARGINAL ZONE LYMPHOMAS (MZL) WITH RITUXIMAB: AN IELSG PHASE II STUDY
Conconi A, Thieblemont C, Martinelli G, Ferreri A, Ponzoni M, Alietti A, Devizzi L, Gianni M, Coiffier B, Cavalli F, Zucca E
Reprint (PDF) version

Oral communication
MOLECULAR FOLLOW-UP IN GASTRIC MALT LYMPHOMAS: PRELIMINARY RESULTS OF THE PROSPECTCIVE LY03 RANDOMISED COOPERATIVE TRIAL
F. Bertoni, A. Conconi, C. Capella, T. Motta, R. Giardini, M. Ponzoni, D. Novero, E. Pedrinis, P. Rinaldi, A. Biondi, F. Cavalli, A.C. Wotherspoon, E. Zucca
Reprint (PDF) version
ielsg
AMERICAN UROLOGY ASSOCIATION Annual Meeting
June 2-7, 2001 Anaheim, California

Podium presentation
PATTERNS OF SURVIVAL IN PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA (DLCL) OF THE TESTIS: AN INTERNATIONAL SURVEY OF 373 PATIENTS
Emanuele Zucca, Annarita Conconi, Tariq I Mughal, Andreas H Sarris, Umberto Vitolo, Richard Klasa, Peter WM Johnson, Massimo A Gianni, John F Seymour, Mamuht Ozsahin, Sergio Cortelazzo, Andrés JM Ferreri, Achille Ambrosetti, Maurizio Martelli, Catherine Thieblemont, Giovanni Martinelli, Graziella Pinotti, Monica Balzarotti, Mariano Provencio, Henry M Gomez, Vincenzo Callea, Francesco Callea, Galafteon Oltean, Franco Cavalli, Mary K Gospodarowicz*. International Extranodal Lymphoma Study Group, Switzerland
Reprint (PDF) version
ielsg
AMERICAN SOCIETY OF CLINICAL ONCOLOGY 37th Annual Meeting
May 12-15, 2001 Anaheim, California

Poster presentation
AN INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG) PHASE II STUDY OF RITUXIMAB IN EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMAS (MZL)
Conconi A, Thieblemont C, Martinelli G, Ferreri A, Ponzoni M, Alietti A, Devizzi L, Gianni M, Coiffier B, Cavalli F, Zucca E on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Reprint (PDF) version
ielsg
AMERICAN SOCIETY OF HEMATOLOGY 42nd Annual Meeting
December 1-5, 2000 San Francisco, California

Poster presentation
PATTERNS OF SURVIVAL IN PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA (DLCL) OF THE TESTIS: AN INTERNATIONAL SURVEY OF 373 PATIENTS
Zucca E., Conconi A., Mughal T.I., Sarris A.H., Vitolo U. and Gospodarowicz M..K on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Reprint (PDF) version

Oral communication
THERAPEUTIC MANAGEMENT OF IMMUNOCOMPETENT PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNLS): ANALYSIS OF AN INTERNATIONAL MULTICENTRE SERIES OF 378 PATIENTS
Ferreri AJM, Reni M, Pasini F, Tirelli U, Calderoni A, Pivnik A, Aondio GM, Ferrarese F, Gomez H, Ponzoni M, Borisch B, Berger F, Chassagne C, Iuzzolino P, Carbone A, Weis J, Pedrinis E, Motta T, Bernardi M, Conroy T, Barbui T, Cavalli F and Blay J-Y
Reprint (PDF) version

Poster presentation
PREDICTORS OF RESPONSE AND SURVIVAL IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNLS): ANALYSIS OF AN INTERNATIONAL MULTICENTRE SERIES OF 378 IMMUNOCOMPETENT PATIENTS
Ferreri AJM, Blay J-Y, Pasini F, Spina M, Vavassori V, Ambrosetti A, Calderoni A, Rossi A, Conconi A, Devizzi L, Berger F, Ponzoni M, Borisch B, Tinguely M, Cerati M, Milani M, Kaplanskaia I, Orvieto E, Sanchez J, Chevreau C, Camba L, Villa E and Cavalli F.
Reprint (PDF) version

Poster presentation
INTRAOCULAR LYMPHOMA (IOL): TREATMENT AND OUTCOME IN HIV- PATIENTS
Ferreri AJM, Blay J-Y, Reni M, Gubkin A, Dell’Oro S, Zucca E, Cortelazzo SF, Ciceri F, Thyss A, Chassagne C, Tinguely M, Borisch B, Berger F, Ponzoni M and Cavalli F.
Reprint (PDF) version

Poster presentation
PRIMARY MEDIASTINAL LYMPHOMA: A MULTICENTER STUDY BY THE IELSG
P. Zinzani, M. Martelli, M. Bertini, E. Zucca, on behalf of the International Extranodal Lymphoma Study Group
Reprint (PDF) version
ielsg
EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY 25th Annual Meeting
October 13-17, 2000 Hamburg, Germany

Oral communication
NON-GASTRIC MALT LYMPHOMAS: A SURVEY OF 369 PATIENTS - THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG)
Zucca E, Conconi A, Roggero E, Ascani S, Campo E, Capella C, Fraternali G, Giardini R, Ponzoni M, Pedrinis E.
Reprint (PDF) version
ielsg
AMERICAN SOCIETY OF CLINICAL ONCOLOGY 36th Annual Meeting
May 20-23, 2000 New Orleans, Louisiana

Oral communication
INTERIM EVALUATION OF GASTRIC MALT LYMPHOMA RESPONSE TO ANTIBIOTICS IN THE ONGOING LY03 RANDOMIZED COOPERATIVE TRIAL OF OBSERVATION VS. CHLORAMBUCIL AFTER ANTI-HELICOBACTER THERAPY
E. Zucca, E. Roggero, J. Delchier, P. Smith, C. Copie-bergmann, C. Traullé, S. Cortelazzo, A. J. Ferreri, A. Ambrosetti, G. Pinotti, F. Cavalli, R. L. Souhami: IELSG, Bellinzona, Switzerland; GELA, Paris, France; UKLG, London, UK.
Reprint (PDF) version
ielsg
AMERICAN SOCIETY OF HEMATOLOGY 41st Annual Meeting
December 3-7, 1999 New Orleans, Louisiana

EXTRANODAL NON-GASTRIC MALT LYMPHOMAS: AN INTERNATIONAL SURVEY OF 278 CASES
E. Roggero, E. Zucca, S. Cortelazzo, A. Rossi, M. Gospodarowicz, A. Ambrosetti, E. Montserrat, G. Pinotti, A. Ferreri, U. Vitolo, M. Bertini, C. Tondini, R. Segati, A. Pileri, M. Balzarotti, L. Baldini, M. Giordano, P. Zinzani, F. Bertoni, T. Motta, B.J. Patterson, F. Menestrina, E. Campo, C. Capella, M. Ponzoni, D. Novero, R. Giardini, R. Barbazza, B. Borisch, S. Cogliatti, B. Piatti, A. Pilatti, D. Rahal, G. Pruneri, G. Tomasic, P. Rinaldi, M. Harris, G. Fraternali-Orcioni, S. Ascani, F. Cavalli, S. Pileri, E. Pedrinis, on behalf of the International Extranodal Lymphoma Study Group (IELSG)
Reprint (PDF) version

Oral communication
TREATMENT OUTCOME AND PROGNOSTIC FACTORS IN PATIENTS WITH LOCALIZED PRIMARY GASTROINTESTINAL (GI) DIFFUSE LARGE CELL LYMPHOMA
S. Cortelazzo, A. Rossi, E. Roggero, E. Oldani, E. Zucca, G.A. Pangalis, P. Zinzani, A. Ferreri, L. Devizzi, L. Baldini, A. Ambrosetti, F. Pasini, G. Pinotti, F. Cavalli, T. Barbui. The International Extranodal Lymphoma Study Group (IELSG)
Reprint (PDF) version
ielsg
SEVENTH INTERNATIONAL CONFERENCE OF MALIGNANT LYMPHOMA
June 2-5, 1999 Lugano, Switzerland

Poster presentation
THE INTERNATIONAL PROGNOSTIC INDEX (IPI) CORRELATES TO SURVIVAL IN PATIENTS WITH LOCALIZED PRIMARY GASTRIC DIFFUSE LARGE B-CELL LYMPHOMA (PGL)
S. Cortelazzo, A. Rossi, E. Roggero, E. Oldani, E. Zucca, C. Tondini, A. Ambrosetti, G. Pinotti, M. Bertini, M. Busetto, L. Gianni, A. Ferreri, G. Martinelli, L. Baldini, F. Cavalli and T. Barbui for the International Extranodal Lymphoma Study Group (IELSG)
Reprint (PDF) version

Oral presentation
EARLY INTERIM REPORT OF THE LY03 RANDOMISED COOPERATIVE TRIAL OF OBSERVATION vs. CHLORAMBUCIL AFTER ANTI-HELICOBACTER THERAPY IN LOW-GRADE GASTRIC LYMPHOMA
Zucca E., Roggero E., Traullé C., Delchier J.C., Smith P., Pedrinis E., Motta T., Capella C., Copie-Bergmann C., Wotherspoon A. and Souhami R. for the International Extranodal Lymphoma Study Group (IELSG), the Groupe d’Étude des Lymphomes de l’Adulte (GELA) and the United Kingdom Lymphoma Group (UKLG)
Reprint (PDF) version
ielsg
AMERICAN SOCIETY OF CLINICAL ONCOLOGY 35th Annual Meeting
May 15-18, 1999 Atlanta, Georgia

Oral communication
PATIENT-SPECIFIC MOLECULAR MONITORING OF MALT-LYMPHOMA AFTER ANTIBIOTIC TREATMENT
Emanuele Zucca, Francesco Bertoni, Enrico Roggero, Michela Gisi, Franco Cavalli for the International Extranodal Lymphoma Study Group (IELSG)
Reprint (PDF) version
ielsg
AMERICAN SOCIETY OF HEMATOLOGY 40th Annual Meeting
December, 1998 Miami Beach, Florida

Poster presentation
INTERNATIONAL PROGNOSTIC INDEX (IPI) EFFECTIVELY PREDICTS CLINICAL OUTCOME OF LOCALISED PRIMARY GASTRIC DIFFUSE LARGE B-CELL LYMPHOMA
S.Cortelazzo, A.Rossi, E.Roggero, E.Oldani, E.Zucca, C.Tondini, A.Ambrosetti, G.Pinotti, M.Bertini, M.Busetto, L.Gianni, F.Cavalli and T.Barbui for the International Extranodal Lymphoma Study Group (IELSG)
Reprint (PDF) version



to top











A wristwatch is additionally a investment decision when you invest in a tag heuer replica uk check out. This is especially true when you try to find a check out that's wristwatches or maybe different cherished gallstones tag heuer replica uk the item, in addition to if at all constructed from silver or maybe stainless steel. A high-priced check out also can employ a sapphire crystal clear, turning it into value all the more seeing that replica watches would be the minute most expensive cherished jewel. This crystal clear would be the handle above the experience on the check out. Almost all tag heuer replica uk employ a a glass crystal clear. The middle of cost wristwatches often have some sort of vitamin crystal clear, that's considerably the start repellent and is particularly not as breakable seeing that cartier replica uk. Sapphire can certainly solely possibly be scored by way of diamonds and is particularly extremely hard to help bust. We should look at exactly what do complete a rolex replica much more high priced. Primary the well known items matter are the products helpful to produce this check out.